Skip to main content
Premium Trial:

Request an Annual Quote

Tom Picone, Cyril Ducet, Larry Lemanski

The Licensing Executives Society has elected Tom Picone as president, LES said during its annual meeting last week in Vancouver, BC, Canada.
Piccone is currently vice president of strategic alliances for Schering-Plough, and is the first pharmaceutical company executive to be elected to LES’ presidency.

The Burnham Institute for Medical Research last week said that Cyril Doucet has been appointed vice president of operations and administration for Burnham at Lake Nona in Orlando, Fla.
Burnham said that Doucet will be responsible for managing the institute’s operations in Orlando as it prepares to move from its temporary facilities there to its planned permanent campus in Lake Nona, Fla.
Prior to joining the institute, Doucet served as vice president, chief administrative officer, and secretary-treasurer at the Trudeau Institute in Saranac Lake, NY. He has also held positions as assistant to the senior vice president of laboratories at the National Research Council in Ottawa, Canada, and vice president of administration and secretary-treasurer at the Paper Research Institute of Canada in Montreal.

Larry Lemanski has been named senior vice president for research and strategic initiatives at Temple University, Temple announced recently.
Lemanski will join Temple from Florida Atlantic University, where he is currently vice president for research, the university’s first, a position he has held for six years. Lemanski will begin his appointment at Temple on Dec. 1, and will oversee all aspects of Temple's research enterprise, including administration of sponsored research; technology transfer and commercialization of the university's intellectual property; research infrastructure; and compliance with federal, state, and university research regulations.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more